Supplement | HBS Case Collection | January 2006 (Revised May 2007)

Endo Pharmaceuticals (C): An "At Risk" Launch?

by Richard G. Hamermesh and Brian DeLacey

Keywords: Product Launch; Risk and Uncertainty; Pharmaceutical Industry;

Citation:

Hamermesh, Richard G., and Brian DeLacey. Endo Pharmaceuticals (C): An "At Risk" Launch? Harvard Business School Supplement 806-066, January 2006. (Revised May 2007.)